REPAGLINIDE

REPAGLINIDE was reported 7566 times

REPAGLINIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 12 0.9231
1 PROTHROMBIN CONSUMPTION TIME PROLONGED 9 0.5625
2 ANTI FACTOR V ANTIBODY 12 0.4286
3 ARTERIOVENOUS FISTULA SITE HAEMATOMA 4 0.2353
4 VIPOMA 5 0.2174
5 POLYMERASE CHAIN REACTION 8 0.0708
6 CONGENITAL UTERINE ANOMALY 6 0.0550
7 HYPOGLYCAEMIC COMA 134 0.0464
8 BENIGN PANCREATIC NEOPLASM 7 0.0368
9 DRUG HALF-LIFE INCREASED 4 0.0351
10 HYPOGLYCAEMIC ENCEPHALOPATHY 13 0.0334
11 GASTRODUODENAL ULCER 14 0.0333
12 SWEAT GLAND TUMOUR 7 0.0298
13 STRESS ULCER 5 0.0253
14 RENAL ARTERIOSCLEROSIS 6 0.0246
15 OESOPHAGEAL PERFORATION 20 0.0240
16 AUTOIMMUNE NEPHRITIS 4 0.0182
17 POVERTY OF SPEECH 7 0.0179
18 FAECAL VOMITING 9 0.0169
19 PENIS INJURY 6 0.0167
20 HYPOGLYCAEMIA 801 0.0165
21 GINGIVAL ABSCESS 12 0.0159
22 MECHANICAL URTICARIA 7 0.0149
23 SOFT TISSUE NECROSIS 10 0.0146
24 RESTING TREMOR 9 0.0139
25 GLOMERULONEPHRITIS MINIMAL LESION 10 0.0138
26 VASCULAR PURPURA 19 0.0136
27 WRONG DRUG 5 0.0129
28 ASPERGILLOMA 4 0.0125
29 LACTIC ACIDOSIS 386 0.0119
30 DIABETIC HYPEROSMOLAR COMA 5 0.0116
31 URINE LEUKOCYTE ESTERASE POSITIVE 8 0.0114
32 GLOMERULOSCLEROSIS 7 0.0111
33 GLOMERULONEPHRITIS MEMBRANOUS 13 0.0111
34 ANGIODYSPLASIA 4 0.0110
35 BRONCHOPNEUMOPATHY 4 0.0109
36 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 9 0.0107
37 ADENOMA BENIGN 9 0.0105
38 INTESTINAL PSEUDO-OBSTRUCTION 9 0.0102
39 CELL DEATH 20 0.0101
40 RENAL ABSCESS 8 0.0098
41 ABDOMINAL CAVITY DRAINAGE 4 0.0095
42 PHARYNGEAL MASS 5 0.0094
43 PEMPHIGOID 71 0.0094
44 CHONDROCALCINOSIS PYROPHOSPHATE 7 0.0091
45 RENAL APLASIA 6 0.0085
46 PERICARDIAL HAEMORRHAGE 18 0.0082
47 SPONTANEOUS HAEMATOMA 6 0.0080
48 EUGLYCAEMIC DIABETIC KETOACIDOSIS 33 0.0080
49 PANCREATIC NEUROENDOCRINE TUMOUR 5 0.0078
50 SKIN SENSITISATION 8 0.0077
51 GLYCOSURIA 10 0.0074
52 HAEMOGLOBINURIA 8 0.0071
53 PROTEUS INFECTION 5 0.0070
54 HYPERPLASIA 6 0.0067
55 DIABETES MELLITUS INADEQUATE CONTROL 116 0.0065
56 SUPRAVENTRICULAR EXTRASYSTOLES 22 0.0065
57 COAGULATION TEST ABNORMAL 5 0.0065
58 MYOPERICARDITIS 5 0.0064
59 BLOOD OSMOLARITY DECREASED 4 0.0064
60 SHOCK HAEMORRHAGIC 52 0.0064
61 DERMATITIS EXFOLIATIVE GENERALISED 22 0.0063
62 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11 0.0062
63 LEUKOCYTOCLASTIC VASCULITIS 10 0.0061
64 PYELONEPHRITIS ACUTE 12 0.0061
65 DEVICE RELATED THROMBOSIS 6 0.0061
66 ANAEMIA HAEMOLYTIC AUTOIMMUNE 5 0.0060
67 SOPOR 80 0.0060
68 TESTICULAR DISORDER 6 0.0060
69 CEREBELLAR SYNDROME 13 0.0059
70 CALCULUS BLADDER 8 0.0059
71 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
72 RENAL TUBULAR INJURY 7 0.0058
73 DIABETIC METABOLIC DECOMPENSATION 8 0.0058
74 URINE KETONE BODY PRESENT 9 0.0057
75 HYPERKALAEMIA 199 0.0057
76 DELAYED GRAFT FUNCTION 4 0.0056
77 HYPOGLYCAEMIC SEIZURE 5 0.0055
78 INTRA-ABDOMINAL HAEMORRHAGE 13 0.0055
79 NORMOCYTIC ANAEMIA 8 0.0054
80 CEREBRAL HAEMATOMA 18 0.0054
81 ANION GAP INCREASED 7 0.0052
82 PANCREATIC CYST 10 0.0052
83 BRADYPHRENIA 34 0.0052
84 HYPOCOAGULABLE STATE 5 0.0051
85 PYURIA 5 0.0051
86 METABOLIC SYNDROME 8 0.0049
87 XEROSIS 6 0.0048
88 KOUNIS SYNDROME 11 0.0048
89 EXPOSURE TO SARS-COV-2 8 0.0047
90 GASTROINTESTINAL WALL THICKENING 7 0.0047
91 GALLBLADDER ENLARGEMENT 5 0.0046
92 CONTRAINDICATION TO MEDICAL TREATMENT 7 0.0046
93 CORONAVIRUS INFECTION 30 0.0045
94 POLYMYOSITIS 8 0.0045
95 POTENTIATING DRUG INTERACTION 15 0.0045
96 GASTROINTESTINAL STOMA COMPLICATION 7 0.0045
97 HEPATITIS FULMINANT 13 0.0044
98 ELECTROCARDIOGRAM CHANGE 4 0.0042
99 HAEMATOMA MUSCLE 5 0.0042
100 HEPATITIS ACUTE 27 0.0042
101 FOOD AVERSION 7 0.0041
102 HENOCH-SCHONLEIN PURPURA 9 0.0041
103 PANCREATIC ENZYMES INCREASED 6 0.0041
104 DIABETIC NEPHROPATHY 9 0.0041
105 ISCHAEMIC STROKE 71 0.0040
106 HEPATOCELLULAR INJURY 56 0.0039
107 ISCHAEMIC CARDIOMYOPATHY 12 0.0039
108 ADENOCARCINOMA PANCREAS 5 0.0039
109 PANCREATIC CARCINOMA METASTATIC 11 0.0039
110 HYPERGLYCAEMIA 140 0.0038
111 PNEUMONIA KLEBSIELLA 7 0.0038
112 PACKED RED BLOOD CELL TRANSFUSION 5 0.0038
113 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
114 ACUTE KIDNEY INJURY 575 0.0038
115 ANAEMIA MACROCYTIC 8 0.0037
116 MUSCLE HAEMORRHAGE 15 0.0037
117 PANCREATITIS ACUTE 84 0.0037
118 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0037
119 HEPATIC NEOPLASM 12 0.0037
120 HYPERTHERMIA 28 0.0037
121 LINEAR IGA DISEASE 6 0.0036
122 ANURIA 31 0.0036
123 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
124 BUNDLE BRANCH BLOCK LEFT 15 0.0035
125 BLADDER NEOPLASM 6 0.0035
126 ACUTE PRERENAL FAILURE 4 0.0035
127 HYPOMAGNESAEMIA 48 0.0034
128 EPIDIDYMITIS 4 0.0034
129 HYPERSENSITIVITY VASCULITIS 9 0.0034
130 CAPILLARY LEAK SYNDROME 7 0.0034
131 CYTOLYTIC HEPATITIS 11 0.0033
132 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 8 0.0032
133 BLOOD LACTIC ACID INCREASED 17 0.0032
134 INJECTION SITE HYPERSENSITIVITY 10 0.0032
135 ORTHOPNOEA 10 0.0031
136 NOCARDIOSIS 8 0.0031
137 METABOLIC ACIDOSIS 100 0.0031
138 CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0031
139 EOSINOPHILIA 54 0.0031
140 ABDOMINAL WALL HAEMATOMA 6 0.0031
141 BRADYARRHYTHMIA 5 0.0030
142 HYPOGLYCAEMIC UNCONSCIOUSNESS 6 0.0030
143 NEUROLOGICAL DECOMPENSATION 7 0.0030
144 RASH MACULO-PAPULAR 67 0.0030
145 EXTRASYSTOLES 21 0.0030
146 ANAL INCONTINENCE 27 0.0030
147 PYELONEPHRITIS 26 0.0030
148 ATRIOVENTRICULAR BLOCK COMPLETE 20 0.0030
149 HYPERLACTACIDAEMIA 8 0.0030
150 CHOLESTASIS 57 0.0030
151 KLEBSIELLA INFECTION 15 0.0030
152 HYPOVOLAEMIC SHOCK 14 0.0029
153 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
154 SERUM FERRITIN DECREASED 5 0.0029
155 PSYCHOMOTOR RETARDATION 8 0.0028
156 DRUG LEVEL ABOVE THERAPEUTIC 13 0.0028
157 LIP OEDEMA 12 0.0028
158 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
159 BLOOD GLUCOSE FLUCTUATION 31 0.0028
160 NEPHROGENIC ANAEMIA 13 0.0028
161 HYPOCALCAEMIA 53 0.0028
162 HYPERPARATHYROIDISM SECONDARY 7 0.0028
163 ACUTE CORONARY SYNDROME 23 0.0028
164 LABYRINTHITIS 7 0.0028
165 AGRANULOCYTOSIS 51 0.0027
166 DRUG INTERACTION 435 0.0027
167 LIPASE INCREASED 21 0.0027
168 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 9 0.0027
169 RETROPERITONEAL HAEMATOMA 6 0.0027
170 HEPATIC CYTOLYSIS 34 0.0027
171 HAEMORRHAGIC TRANSFORMATION STROKE 4 0.0027
172 HEPATIC CYST 9 0.0026
173 DIABETIC KETOACIDOSIS 62 0.0026
174 APLASIA 5 0.0026
175 DUODENAL ULCER 18 0.0025
176 OCCULT BLOOD POSITIVE 5 0.0025
177 HEPATITIS E 4 0.0025
178 VENTRICULAR FIBRILLATION 28 0.0025
179 LACUNAR INFARCTION 6 0.0025
180 TOXIC SKIN ERUPTION 25 0.0025
181 ECCHYMOSIS 17 0.0025
182 VITAMIN B12 DEFICIENCY 10 0.0025
183 CUTANEOUS VASCULITIS 9 0.0025
184 PERIPHERAL ISCHAEMIA 10 0.0024
185 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 63 0.0024
186 COMA SCALE ABNORMAL 7 0.0024
187 DERMATITIS EXFOLIATIVE 12 0.0024
188 NEPHRITIS 8 0.0024
189 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
190 MELAENA 52 0.0024
191 FEBRILE BONE MARROW APLASIA 10 0.0024
192 URINE ANALYSIS ABNORMAL 7 0.0023
193 PSEUDOMONAS INFECTION 20 0.0023
194 PURPURA 20 0.0023
195 CHOLESTATIC LIVER INJURY 5 0.0022
196 RALES 13 0.0022
197 TRIGEMINAL NEURALGIA 9 0.0022
198 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
199 DERMATITIS BULLOUS 16 0.0022
200 NEPHROTIC SYNDROME 15 0.0022
201 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
202 FOOD INTOLERANCE 8 0.0022
203 GLYCOSYLATED HAEMOGLOBIN INCREASED 55 0.0022
204 ALTERED STATE OF CONSCIOUSNESS 47 0.0022
205 YELLOW SKIN 10 0.0021
206 SINUS BRADYCARDIA 20 0.0021
207 BICYTOPENIA 4 0.0020
208 INTERNATIONAL NORMALISED RATIO ABNORMAL 7 0.0020
209 LYMPHOEDEMA 14 0.0020
210 POLYMENORRHOEA 7 0.0020
211 MIXED LIVER INJURY 6 0.0020
212 OSTEITIS 5 0.0020
213 NOCTURIA 24 0.0020
214 HYPOTHERMIA 20 0.0020
215 ACUTE PULMONARY OEDEMA 11 0.0020
216 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
217 DRUG LEVEL INCREASED 32 0.0019
218 GASTRITIS EROSIVE 9 0.0019
219 BLOOD CREATININE DECREASED 6 0.0019
220 APLASTIC ANAEMIA 10 0.0019
221 RENAL FAILURE ACUTE 81 0.0019
222 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
223 CARDIAC FAILURE CHRONIC 8 0.0019
224 CHRONIC SINUSITIS 7 0.0019
225 WEIGHT BEARING DIFFICULTY 5 0.0019
226 PORTAL VEIN THROMBOSIS 6 0.0019
227 CATHETER SITE INFECTION 7 0.0018
228 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
229 RHABDOMYOLYSIS 77 0.0018
230 BACTERIAL SEPSIS 6 0.0018
231 HAEMODYNAMIC INSTABILITY 14 0.0018
232 TONGUE OEDEMA 7 0.0018
233 SEPTIC SHOCK 79 0.0018
234 HYPERKERATOSIS 10 0.0018
235 RASH MORBILLIFORM 5 0.0018
236 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
237 HYPERAMMONAEMIA 9 0.0018
238 THERAPEUTIC AGENT TOXICITY 6 0.0018
239 TRANSAMINASES INCREASED 40 0.0018
240 MUSCLE RUPTURE 7 0.0018
241 ENCEPHALOPATHY 44 0.0018
242 CORONARY ARTERY STENOSIS 9 0.0018
243 HAEMODIALYSIS 15 0.0018
244 HAEMOLYTIC ANAEMIA 16 0.0018
245 CARDIAC FAILURE 143 0.0018
246 ARTERIAL OCCLUSIVE DISEASE 14 0.0018
247 RESPIRATORY ACIDOSIS 7 0.0018
248 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
249 BLOOD PRESSURE DIASTOLIC DECREASED 13 0.0018
250 AZOTAEMIA 7 0.0018
251 CEREBRAL ISCHAEMIA 9 0.0017
252 IMMUNE THROMBOCYTOPENIA 8 0.0017
253 DYSARTHRIA 65 0.0017
254 ESCHERICHIA SEPSIS 5 0.0017
255 PERFORMANCE STATUS DECREASED 8 0.0017
256 NEPHROPATHY 16 0.0017
257 HYPERTENSIVE CRISIS 19 0.0017
258 HYPERURICAEMIA 7 0.0017
259 RENAL FAILURE CHRONIC 13 0.0017
260 CONGESTIVE CARDIOMYOPATHY 7 0.0017
261 BLOOD CULTURE POSITIVE 5 0.0017
262 METABOLIC ENCEPHALOPATHY 5 0.0017
263 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
264 REBOUND ACID HYPERSECRETION 5 0.0017
265 VENTRICULAR ARRHYTHMIA 6 0.0016
266 THROMBOCYTOSIS 6 0.0016
267 DIABETIC FOOT 5 0.0016
268 IMMUNE-MEDIATED ENTEROCOLITIS 6 0.0016
269 RENAL TUBULAR NECROSIS 16 0.0016
270 BODY TEMPERATURE DECREASED 16 0.0016
271 FIBROSIS 5 0.0016
272 HAEMATOMA 42 0.0016
273 NECROSIS 9 0.0016
274 CHOLANGITIS 10 0.0016
275 HYPOKINESIA 23 0.0016
276 MYOCARDIAL ISCHAEMIA 18 0.0016
277 HYPERTRANSAMINASAEMIA 11 0.0016
278 FACE INJURY 6 0.0016
279 HAEMATURIA 54 0.0016
280 DYSLIPIDAEMIA 8 0.0016
281 ACIDOSIS 12 0.0016
282 BLOOD GLUCOSE ABNORMAL 29 0.0016
283 IRON DEFICIENCY 7 0.0016
284 TACHYPNOEA 21 0.0015
285 INTERNATIONAL NORMALISED RATIO INCREASED 44 0.0015
286 HYPERTRIGLYCERIDAEMIA 9 0.0015
287 FAECES SOFT 11 0.0015
288 LUNG DISORDER 73 0.0015
289 FACE OEDEMA 25 0.0015
290 DIABETIC RETINOPATHY 5 0.0015
291 SUBDURAL HAEMATOMA 21 0.0015
292 CARDIOGENIC SHOCK 21 0.0015
293 GASTROINTESTINAL TOXICITY 7 0.0015
294 GENERALISED OEDEMA 18 0.0015
295 INTESTINAL ISCHAEMIA 8 0.0015
296 LEFT VENTRICULAR FAILURE 5 0.0015
297 PETECHIAE 15 0.0014
298 PARKINSONISM 14 0.0014
299 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
300 PANCREATIC DISORDER 7 0.0014
301 HYPONATRAEMIA 80 0.0014
302 HAEMATEMESIS 36 0.0014
303 FACIAL PARESIS 5 0.0014
304 JAUNDICE 38 0.0014
305 PROTEIN URINE PRESENT 7 0.0014
306 BLOOD URIC ACID INCREASED 8 0.0014
307 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
308 TOXIC ENCEPHALOPATHY 7 0.0014
309 HYPERCALCAEMIA 17 0.0014
310 WALKING AID USER 9 0.0014
311 HAEMORRHAGIC ANAEMIA 6 0.0014
312 CARDIO-RESPIRATORY ARREST 57 0.0014
313 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
314 POST PROCEDURAL INFECTION 11 0.0014
315 MEDICATION ERROR 75 0.0013
316 TENDON INJURY 5 0.0013
317 MYOCLONUS 16 0.0013
318 ODYNOPHAGIA 8 0.0013
319 KETOACIDOSIS 10 0.0013
320 URINARY TRACT DISORDER 6 0.0013
321 COMA 63 0.0013
322 VASCULAR DEVICE INFECTION 6 0.0013
323 URINE ABNORMALITY 6 0.0013
324 ANAEMIA 250 0.0013
325 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
326 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
327 ONYCHOCLASIS 9 0.0013
328 SKIN PLAQUE 11 0.0013
329 HYPOKALAEMIA 60 0.0013
330 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
331 DIASTOLIC DYSFUNCTION 4 0.0013
332 OLIGURIA 8 0.0013
333 BLOOD GLUCOSE DECREASED 61 0.0013
334 EOSINOPHILIC PNEUMONIA 4 0.0013
335 ORTHOSTATIC HYPOTENSION 22 0.0013
336 SHOCK 29 0.0013
337 URINE OUTPUT DECREASED 11 0.0013
338 RENAL FAILURE 167 0.0013
339 RASH VESICULAR 6 0.0012
340 ANGINA UNSTABLE 8 0.0012
341 MOUTH HAEMORRHAGE 9 0.0012
342 MYOCARDITIS 14 0.0012
343 PRODUCT PRESCRIBING ERROR 29 0.0012
344 ENTEROCOLITIS 7 0.0012
345 METABOLIC DISORDER 7 0.0012
346 FLUID INTAKE REDUCED 6 0.0012
347 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
348 UROSEPSIS 11 0.0012
349 URINE ODOUR ABNORMAL 7 0.0012
350 BRADYKINESIA 7 0.0012
351 BLOOD PRESSURE SYSTOLIC INCREASED 23 0.0012
352 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
353 RENAL IMPAIRMENT 98 0.0012
354 ATRIOVENTRICULAR BLOCK 9 0.0012
355 FRACTURE 22 0.0012
356 SPUTUM DISCOLOURED 11 0.0012
357 ADRENAL INSUFFICIENCY 14 0.0012
358 ACUTE MYOCARDIAL INFARCTION 34 0.0012
359 CEREBRAL HAEMORRHAGE 41 0.0011
360 LARYNGEAL OEDEMA 7 0.0011
361 SKIN REACTION 16 0.0011
362 BLOOD GLUCOSE INCREASED 214 0.0011
363 BLOOD UREA INCREASED 19 0.0011
364 BLOOD CREATININE INCREASED 74 0.0011
365 HEPATITIS 29 0.0011
366 BRADYCARDIA 60 0.0011
367 THROMBOTIC MICROANGIOPATHY 11 0.0011
368 CONFUSIONAL STATE 182 0.0011
369 CHRONIC KIDNEY DISEASE 85 0.0011
370 PANCYTOPENIA 62 0.0011
371 ANGIOEDEMA 49 0.0011
372 DEVICE RELATED INFECTION 17 0.0011
373 RASH PUSTULAR 8 0.0011
374 PANCREATITIS 58 0.0011
375 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
376 ISCHAEMIA 5 0.0011
377 BONE MARROW FAILURE 22 0.0011
378 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
379 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
380 CHOLECYSTITIS ACUTE 6 0.0011
381 INTERSTITIAL LUNG DISEASE 51 0.0011
382 GASTRIC ULCER 20 0.0011
383 MOUTH SWELLING 6 0.0010
384 ACUTE RESPIRATORY FAILURE 20 0.0010
385 DIABETES MELLITUS 79 0.0010
386 WRONG PRODUCT ADMINISTERED 7 0.0010
387 DISORIENTATION 41 0.0010
388 DEHYDRATION 138 0.0010
389 ULCER HAEMORRHAGE 7 0.0010
390 HYPOALBUMINAEMIA 8 0.0010
391 CARDIOPULMONARY FAILURE 4 0.0010
392 EPIGASTRIC DISCOMFORT 4 0.0010
393 INCORRECT DOSAGE ADMINISTERED 5 0.0010
394 ASCITES 30 0.0010
395 COAGULOPATHY 17 0.0010
396 FOOT OPERATION 5 0.0010
397 UNRESPONSIVE TO STIMULI 26 0.0010
398 AUTOIMMUNE HEPATITIS 7 0.0010
399 PRESCRIBED UNDERDOSE 20 0.0010
400 OEDEMA PERIPHERAL 122 0.0010
401 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
402 TRANSPLANT REJECTION 8 0.0010
403 BLOOD DISORDER 8 0.0010
404 HEPATITIS CHOLESTATIC 6 0.0010
405 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
406 LYMPHOPENIA 14 0.0010
407 END STAGE RENAL DISEASE 18 0.0010
408 METASTASIS 7 0.0010
409 RETINAL DETACHMENT 9 0.0010
410 POLYURIA 8 0.0010
411 IRON DEFICIENCY ANAEMIA 9 0.0010
412 VENTRICULAR TACHYCARDIA 16 0.0010
413 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
414 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
415 GASTROENTERITIS 14 0.0010
416 MALABSORPTION 5 0.0010
417 POISONING DELIBERATE 9 0.0009
418 SUDDEN DEATH 10 0.0009
419 RENAL PAIN 10 0.0009
420 GENERAL PHYSICAL HEALTH DETERIORATION 109 0.0009
421 AORTIC VALVE INCOMPETENCE 4 0.0009
422 HYPOTHYROIDISM 30 0.0009
423 CHOLECYSTITIS 11 0.0009
424 LOSS OF CONSCIOUSNESS 118 0.0009
425 HEPATOCELLULAR CARCINOMA 7 0.0009
426 HYPOXIA 32 0.0009
427 HYPOTENSION 182 0.0009
428 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
429 ABDOMINAL ABSCESS 4 0.0009
430 ATRIAL FIBRILLATION 88 0.0009
431 GASTRIC ULCER HAEMORRHAGE 5 0.0009
432 FOOT DEFORMITY 10 0.0009
433 RENAL DISORDER 42 0.0009
434 RESPIRATORY RATE INCREASED 8 0.0009
435 CARDIAC FAILURE ACUTE 6 0.0009
436 HAEMORRHAGIC STROKE 7 0.0009
437 APHASIA 27 0.0009
438 EMPHYSEMA 9 0.0009
439 PRODUCT ADMINISTRATION ERROR 18 0.0009
440 CYANOSIS 14 0.0009
441 DERMATITIS CONTACT 10 0.0009
442 LIMB DISCOMFORT 27 0.0009
443 PLEURAL EFFUSION 53 0.0009
444 DECUBITUS ULCER 7 0.0009
445 HEPATIC ENCEPHALOPATHY 8 0.0009
446 ANKLE FRACTURE 13 0.0008
447 HEPATIC FAILURE 25 0.0008
448 CANDIDA INFECTION 14 0.0008
449 ENTEROCOCCAL INFECTION 4 0.0008
450 THROMBOCYTOPENIA 92 0.0008
451 HYPOPHAGIA 21 0.0008
452 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
453 FLATULENCE 46 0.0008
454 MYOPATHY 7 0.0008
455 SYNCOPE 81 0.0008
456 ASPARTATE AMINOTRANSFERASE INCREASED 43 0.0008
457 HALLUCINATION, VISUAL 17 0.0008
458 MALNUTRITION 9 0.0008
459 BLOOD POTASSIUM INCREASED 13 0.0008
460 CHROMATURIA 18 0.0008
461 BLOOD SODIUM DECREASED 15 0.0008
462 LYMPHOCYTE COUNT DECREASED 14 0.0008
463 BLOOD PRESSURE FLUCTUATION 19 0.0008
464 PROTEINURIA 15 0.0008
465 AMMONIA INCREASED 4 0.0008
466 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
467 FEMORAL NECK FRACTURE 4 0.0008
468 METASTASES TO LUNG 9 0.0008
469 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
470 PROCTALGIA 5 0.0008
471 CACHEXIA 4 0.0008
472 INCOHERENT 5 0.0008
473 HYPERPROLACTINAEMIA 5 0.0008
474 HAEMOGLOBIN DECREASED 79 0.0008
475 HEMIPARESIS 13 0.0008
476 EXTRAPYRAMIDAL DISORDER 19 0.0008
477 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
478 PNEUMONIA ASPIRATION 19 0.0008
479 SCIATICA 12 0.0008
480 ATRIAL FLUTTER 6 0.0008
481 ARTERIOSCLEROSIS 7 0.0007
482 C-REACTIVE PROTEIN INCREASED 27 0.0007
483 METASTASES TO LYMPH NODES 5 0.0007
484 PRESYNCOPE 18 0.0007
485 METASTASES TO LIVER 13 0.0007
486 ARRHYTHMIA 35 0.0007
487 COLD SWEAT 13 0.0007
488 CEREBRAL INFARCTION 18 0.0007
489 SKIN LACERATION 8 0.0007
490 ABNORMAL LOSS OF WEIGHT 5 0.0007
491 CARDIOMEGALY 9 0.0007
492 INFARCTION 5 0.0007
493 CYTOMEGALOVIRUS INFECTION 12 0.0007
494 RECTAL HAEMORRHAGE 31 0.0007
495 FALL 240 0.0007
496 STEVENS-JOHNSON SYNDROME 16 0.0007
497 URINARY RETENTION 24 0.0007
498 NEPHROPATHY TOXIC 8 0.0007
499 OXYGEN SATURATION DECREASED 40 0.0007
500 PAPULE 5 0.0007
501 BLOOD PRESSURE ABNORMAL 14 0.0007
502 RETINAL HAEMORRHAGE 5 0.0007
503 CARDIAC VALVE DISEASE 4 0.0007
504 INFUSION SITE PAIN 9 0.0007
505 ANOREXIA 9 0.0007
506 HEPATIC STEATOSIS 13 0.0007
507 ASTHENIA 261 0.0007
508 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
509 HEART RATE DECREASED 24 0.0007
510 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
511 TEMPERATURE INTOLERANCE 7 0.0007
512 BLOOD IRON DECREASED 8 0.0007
513 BACTERAEMIA 8 0.0007
514 VENTRICULAR EXTRASYSTOLES 7 0.0007
515 CATARACT OPERATION 4 0.0007
516 HEPATOTOXICITY 15 0.0007
517 MYOSITIS 6 0.0007
518 TRANSFUSION 7 0.0007
519 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
520 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
521 IMPAIRED GASTRIC EMPTYING 9 0.0007
522 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
523 DYSURIA 24 0.0007
524 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
525 TASTE DISORDER 13 0.0006
526 FLANK PAIN 6 0.0006
527 NEUTROPENIA 87 0.0006
528 GASTROINTESTINAL PAIN 7 0.0006
529 COLITIS 24 0.0006
530 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
531 BLOOD ALBUMIN DECREASED 5 0.0006
532 TOXICITY TO VARIOUS AGENTS 106 0.0006
533 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
534 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
535 PARAESTHESIA ORAL 9 0.0006
536 MIOSIS 5 0.0006
537 BLOOD CALCIUM DECREASED 7 0.0006
538 PRESCRIBED OVERDOSE 12 0.0006
539 SEPSIS 69 0.0006
540 APATHY 9 0.0006
541 RESPIRATORY TRACT INFECTION 16 0.0006
542 GOUT 11 0.0006
543 ABDOMINAL PAIN 142 0.0006
544 ABNORMAL FAECES 5 0.0006
545 GASTRITIS 16 0.0006
546 VERTIGO 37 0.0006
547 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
548 BLADDER DISORDER 6 0.0006
549 COLON CANCER 9 0.0006
550 EYELID OEDEMA 7 0.0006
551 LEUKOPENIA 30 0.0006
552 BRAIN INJURY 6 0.0006
553 DIARRHOEA 386 0.0006
554 URINARY TRACT INFECTION 101 0.0006
555 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
556 EYELID PTOSIS 6 0.0006
557 RESPIRATORY FAILURE 43 0.0006
558 COGNITIVE DISORDER 27 0.0006
559 GASTROINTESTINAL HAEMORRHAGE 48 0.0006
560 ACCIDENTAL OVERDOSE 21 0.0006
561 MUCOSAL INFLAMMATION 15 0.0006
562 FEBRILE NEUTROPENIA 38 0.0006
563 CARPAL TUNNEL SYNDROME 8 0.0006
564 DEFAECATION URGENCY 4 0.0006
565 INJECTION SITE EXTRAVASATION 7 0.0006
566 TREATMENT NONCOMPLIANCE 31 0.0006
567 DIALYSIS 8 0.0006
568 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
569 CORONARY ARTERY DISEASE 17 0.0006
570 CARDIOTOXICITY 5 0.0006
571 HAEMARTHROSIS 5 0.0006
572 BLOOD BILIRUBIN INCREASED 15 0.0006
573 OROPHARYNGEAL DISCOMFORT 5 0.0006
574 LIMB INJURY 15 0.0006
575 PRODUCT DISPENSING ERROR 12 0.0006
576 PRODUCT PRESCRIBING ISSUE 12 0.0006
577 HYPERTENSION 116 0.0005
578 MUSCULAR WEAKNESS 62 0.0005
579 PNEUMONIA BACTERIAL 5 0.0005
580 HYPERHIDROSIS 70 0.0005
581 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
582 NERVE COMPRESSION 5 0.0005
583 NEUTROPHIL COUNT DECREASED 22 0.0005
584 MIDDLE INSOMNIA 10 0.0005
585 APPENDICITIS 5 0.0005
586 FISTULA 6 0.0005
587 LACERATION 5 0.0005
588 INTESTINAL OBSTRUCTION 20 0.0005
589 HAEMATOTOXICITY 5 0.0005
590 VOMITING 247 0.0005
591 OSTEONECROSIS OF JAW 13 0.0005
592 ANGINA PECTORIS 15 0.0005
593 MOUTH ULCERATION 11 0.0005
594 GASTRIC HAEMORRHAGE 6 0.0005
595 DISTURBANCE IN ATTENTION 28 0.0005
596 DECREASED APPETITE 120 0.0005
597 ELECTROLYTE IMBALANCE 6 0.0005
598 OEDEMA 28 0.0005
599 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
600 STAPHYLOCOCCAL INFECTION 17 0.0005
601 NEEDLE ISSUE 15 0.0005
602 BRONCHITIS 38 0.0005
603 PNEUMONIA 166 0.0005
604 HEPATIC FUNCTION ABNORMAL 19 0.0005
605 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
606 PYREXIA 176 0.0005
607 DISCOMFORT 31 0.0005
608 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
609 EPISTAXIS 38 0.0005
610 DRUG ERUPTION 9 0.0005
611 DYSPNOEA 287 0.0005
612 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
613 INFLAMMATION 26 0.0005
614 PRODUCTIVE COUGH 24 0.0005
615 GINGIVAL PAIN 4 0.0005
616 CYSTITIS 16 0.0005
617 CONSTIPATION 108 0.0005
618 SINUS TACHYCARDIA 7 0.0005
619 VISUAL IMPAIRMENT 61 0.0005
620 DRY THROAT 5 0.0005
621 SUBARACHNOID HAEMORRHAGE 5 0.0005
622 ASPHYXIA 4 0.0005
623 SMALL INTESTINAL OBSTRUCTION 6 0.0005
624 WEIGHT DECREASED 136 0.0005
625 HEART RATE IRREGULAR 11 0.0005
626 HELICOBACTER INFECTION 5 0.0005
627 ACCIDENTAL UNDERDOSE 7 0.0005
628 PHOTOSENSITIVITY REACTION 8 0.0005
629 ILEUS 6 0.0005
630 HYPERBILIRUBINAEMIA 5 0.0005
631 HEMIPLEGIA 4 0.0005
632 SECRETION DISCHARGE 6 0.0005
633 WEIGHT FLUCTUATION 5 0.0005
634 DYSPNOEA EXERTIONAL 18 0.0005
635 HALLUCINATION 36 0.0005
636 RESPIRATORY DISTRESS 13 0.0005
637 CHEST PAIN 87 0.0005
638 HAEMOPTYSIS 13 0.0005
639 ANAPHYLACTIC SHOCK 12 0.0005
640 BLOOD PRESSURE INCREASED 71 0.0005
641 DYSPHAGIA 44 0.0005
642 BALANCE DISORDER 40 0.0005
643 FAECES DISCOLOURED 10 0.0005
644 OESOPHAGITIS 5 0.0005
645 INTENTIONAL PRODUCT MISUSE 40 0.0005
646 POLLAKIURIA 19 0.0005
647 PULMONARY CONGESTION 6 0.0005
648 HEPATIC ENZYME INCREASED 31 0.0005
649 MUSCULOSKELETAL CHEST PAIN 7 0.0005
650 TENDONITIS 7 0.0005
651 BLOOD PRESSURE DECREASED 30 0.0005
652 LUNG INFECTION 7 0.0005
653 EYE HAEMORRHAGE 6 0.0004
654 ACUTE MYELOID LEUKAEMIA 7 0.0004
655 THERAPY PARTIAL RESPONDER 7 0.0004
656 LIVER INJURY 11 0.0004
657 JOINT RANGE OF MOTION DECREASED 6 0.0004
658 ORAL PAIN 10 0.0004
659 DRUG-INDUCED LIVER INJURY 14 0.0004
660 TYPE 2 DIABETES MELLITUS 15 0.0004
661 INTESTINAL PERFORATION 5 0.0004
662 DYSSTASIA 13 0.0004
663 PRURITUS 170 0.0004
664 MITRAL VALVE INCOMPETENCE 5 0.0004
665 PNEUMONITIS 12 0.0004
666 ABSCESS 7 0.0004
667 RENAL INJURY 13 0.0004
668 INTENTIONAL OVERDOSE 28 0.0004
669 AGITATION 32 0.0004
670 RESPIRATORY ARREST 12 0.0004
671 HIP FRACTURE 14 0.0004
672 PERICARDIAL EFFUSION 10 0.0004
673 MENTAL STATUS CHANGES 12 0.0004
674 PREMATURE BABY 13 0.0004
675 PULMONARY EMBOLISM 41 0.0004
676 MALAISE 188 0.0004
677 METASTASES TO BONE 7 0.0004
678 BLINDNESS UNILATERAL 6 0.0004
679 COVID-19 PNEUMONIA 5 0.0004
680 GAIT DISTURBANCE 81 0.0004
681 INFUSION RELATED REACTION 28 0.0004
682 PLATELET COUNT DECREASED 45 0.0004
683 ATAXIA 5 0.0004
684 DRUG PRESCRIBING ERROR 8 0.0004
685 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
686 PANCREATIC CARCINOMA 12 0.0004
687 GLAUCOMA 8 0.0004
688 HYPERTHYROIDISM 6 0.0004
689 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
690 FLUID RETENTION 21 0.0004
691 SUICIDE ATTEMPT 25 0.0004
692 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
693 SOMNOLENCE 83 0.0004
694 ABDOMINAL DISTENSION 43 0.0004
695 CARDIAC ARREST 34 0.0004
696 SCHIZOPHRENIA 5 0.0004
697 CARDIAC FAILURE CONGESTIVE 33 0.0004
698 HEPATOMEGALY 4 0.0004
699 CARDIOMYOPATHY 6 0.0004
700 DELIRIUM 14 0.0004
701 PULMONARY MASS 6 0.0004
702 CONDITION AGGRAVATED 122 0.0004
703 RESPIRATORY DISORDER 12 0.0004
704 SPEECH DISORDER 21 0.0004
705 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
706 NEUROTOXICITY 7 0.0004
707 DIVERTICULITIS 11 0.0004
708 HEAD DISCOMFORT 7 0.0004
709 FEEDING DISORDER 8 0.0004
710 DYSKINESIA 16 0.0004
711 DRUG ADMINISTRATION ERROR 12 0.0004
712 FUNGAL INFECTION 13 0.0004
713 SKIN DISORDER 13 0.0004
714 LEUKOCYTOSIS 7 0.0004
715 TOOTHACHE 7 0.0004
716 HIATUS HERNIA 5 0.0004
717 EJECTION FRACTION DECREASED 6 0.0004
718 DEEP VEIN THROMBOSIS 25 0.0004
719 OVERDOSE 82 0.0004
720 SARS-COV-2 TEST POSITIVE 5 0.0004
721 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
722 RASH ERYTHEMATOUS 18 0.0004
723 DYSPHONIA 22 0.0004
724 FEELING HOT 23 0.0004
725 BODY HEIGHT DECREASED 4 0.0004
726 CONTUSION 36 0.0004
727 DRUG INTOLERANCE 36 0.0004
728 UNDERDOSE 27 0.0004
729 BLOOD URINE PRESENT 7 0.0004
730 PALLOR 10 0.0004
731 GINGIVAL BLEEDING 5 0.0004
732 ACUTE HEPATIC FAILURE 5 0.0004
733 LETHARGY 21 0.0004
734 PULMONARY FIBROSIS 7 0.0004
735 OSTEOPOROSIS 15 0.0004
736 PERIPHERAL COLDNESS 5 0.0004
737 ERUCTATION 7 0.0004
738 TACHYCARDIA 32 0.0004
739 HUNGER 5 0.0004
740 DEMENTIA 10 0.0004
741 MASS 5 0.0004
742 GYNAECOMASTIA 11 0.0004
743 DIZZINESS 177 0.0004
744 INJECTION SITE MASS 13 0.0004
745 ABDOMINAL PAIN UPPER 72 0.0003
746 HEAD INJURY 11 0.0003
747 MYELODYSPLASTIC SYNDROME 5 0.0003
748 LIVER FUNCTION TEST ABNORMAL 10 0.0003
749 FLUID OVERLOAD 5 0.0003
750 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
751 CHEST DISCOMFORT 35 0.0003
752 NAUSEA 269 0.0003
753 CELLULITIS 17 0.0003
754 PULMONARY HYPERTENSION 7 0.0003
755 THIRST 6 0.0003
756 HAEMORRHAGE 35 0.0003
757 LOCALISED INFECTION 8 0.0003
758 HERPES ZOSTER 19 0.0003
759 TREMOR 54 0.0003
760 GASTROINTESTINAL DISORDER 29 0.0003
761 PRURITUS GENERALISED 7 0.0003
762 FEMUR FRACTURE 10 0.0003
763 BACTERIAL INFECTION 6 0.0003
764 WEIGHT INCREASED 72 0.0003
765 BASAL CELL CARCINOMA 5 0.0003
766 SWOLLEN TONGUE 10 0.0003
767 HEPATIC CIRRHOSIS 6 0.0003
768 PAIN IN EXTREMITY 94 0.0003
769 OCULAR HYPERAEMIA 15 0.0003
770 COLITIS ULCERATIVE 14 0.0003
771 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
772 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
773 RASH GENERALISED 8 0.0003
774 HAEMORRHOIDS 6 0.0003
775 NECK PAIN 17 0.0003
776 MANIA 5 0.0003
777 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
778 ASTHMA 34 0.0003
779 RESTLESSNESS 11 0.0003
780 RASH 131 0.0003
781 CYTOKINE RELEASE SYNDROME 6 0.0003
782 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
783 PRODUCT PREPARATION ERROR 6 0.0003
784 CORONARY ARTERY OCCLUSION 4 0.0003
785 FATIGUE 227 0.0003
786 PALPITATIONS 34 0.0003
787 MENTAL IMPAIRMENT 7 0.0003
788 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
789 MYALGIA 49 0.0003
790 FEELING COLD 8 0.0003
791 ERYTHEMA 59 0.0003
792 DERMATITIS 6 0.0003
793 SYRINGE ISSUE 5 0.0003
794 OSTEOARTHRITIS 12 0.0003
795 CHILLS 33 0.0003
796 BRONCHOSPASM 4 0.0003
797 STOMATITIS 17 0.0003
798 GALLBLADDER DISORDER 5 0.0003
799 OFF LABEL USE 245 0.0003
800 POOR QUALITY SLEEP 6 0.0003
801 PRODUCT SUBSTITUTION ISSUE 16 0.0003
802 OSTEOMYELITIS 5 0.0003
803 MENTAL DISORDER 12 0.0003
804 COUGH 77 0.0003
805 CHOLELITHIASIS 9 0.0003
806 COVID-19 48 0.0003
807 NEUROPATHY PERIPHERAL 26 0.0003
808 SKIN ULCER 7 0.0003
809 BLINDNESS 11 0.0003
810 DIPLOPIA 7 0.0003
811 CATARACT 16 0.0003
812 URTICARIA 45 0.0003
813 PULMONARY OEDEMA 12 0.0003
814 HAEMORRHAGE INTRACRANIAL 4 0.0003
815 CARDIAC DISORDER 25 0.0003
816 BACK PAIN 62 0.0003
817 ANHEDONIA 7 0.0003
818 PRODUCT AVAILABILITY ISSUE 6 0.0003
819 FEELING JITTERY 5 0.0003
820 AMNESIA 17 0.0003
821 HIP ARTHROPLASTY 4 0.0003
822 SWELLING FACE 17 0.0003
823 THROMBOSIS 21 0.0003
824 SKIN LESION 7 0.0003
825 ILLNESS 26 0.0003
826 HAEMATOCRIT DECREASED 5 0.0003
827 MUSCULOSKELETAL STIFFNESS 22 0.0003
828 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
829 NIGHT SWEATS 8 0.0002
830 LIVER DISORDER 11 0.0002
831 INTENTIONAL SELF-INJURY 5 0.0002
832 THROAT IRRITATION 11 0.0002
833 RED BLOOD CELL COUNT DECREASED 7 0.0002
834 HYPERSOMNIA 7 0.0002
835 DYSPEPSIA 24 0.0002
836 IMPAIRED HEALING 8 0.0002
837 EYE DISORDER 8 0.0002
838 RIB FRACTURE 5 0.0002
839 TOOTH LOSS 5 0.0002
840 NEPHROLITHIASIS 11 0.0002
841 GAIT INABILITY 8 0.0002
842 BONE PAIN 14 0.0002
843 KNEE ARTHROPLASTY 5 0.0002
844 ABDOMINAL PAIN LOWER 6 0.0002
845 DISEASE PROGRESSION 28 0.0002
846 URINARY INCONTINENCE 7 0.0002
847 HAEMATOCHEZIA 13 0.0002
848 EATING DISORDER 5 0.0002
849 ARTHRALGIA 97 0.0002
850 INFLUENZA 26 0.0002
851 BLOOD POTASSIUM DECREASED 7 0.0002
852 ABDOMINAL DISCOMFORT 39 0.0002
853 HEART RATE INCREASED 23 0.0002
854 BLISTER 13 0.0002
855 THERAPEUTIC RESPONSE DECREASED 14 0.0002
856 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
857 DEAFNESS 6 0.0002
858 ECZEMA 12 0.0002
859 DYSGEUSIA 17 0.0002
860 RASH MACULAR 8 0.0002
861 NASOPHARYNGITIS 42 0.0002
862 PERIPHERAL SWELLING 35 0.0002
863 SLEEP DISORDER 16 0.0002
864 LYMPHADENOPATHY 8 0.0002
865 EAR INFECTION 6 0.0002
866 INJECTION SITE HAEMORRHAGE 18 0.0002
867 INSOMNIA 60 0.0002
868 CEREBROVASCULAR ACCIDENT 38 0.0002
869 RASH PAPULAR 5 0.0002
870 INFECTION 32 0.0002
871 HYPERSENSITIVITY 41 0.0002
872 PRODUCT USE ISSUE 41 0.0002
873 MOVEMENT DISORDER 7 0.0002
874 PROCEDURAL PAIN 6 0.0002
875 ARTHRITIS 17 0.0002
876 PARAESTHESIA 34 0.0002
877 OROPHARYNGEAL PAIN 20 0.0002
878 BREAST CANCER 20 0.0002
879 SWELLING 20 0.0002
880 EYE PAIN 12 0.0002
881 VISION BLURRED 29 0.0002
882 VISUAL ACUITY REDUCED 7 0.0002
883 MUSCULOSKELETAL PAIN 11 0.0002
884 HYPOACUSIS 9 0.0002
885 DYSTONIA 4 0.0002
886 LABORATORY TEST ABNORMAL 6 0.0002
887 ABASIA 5 0.0002
888 PAIN 123 0.0002
889 GASTRIC CANCER 5 0.0002
890 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
891 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
892 DRUG RESISTANCE 5 0.0002
893 LUNG NEOPLASM MALIGNANT 8 0.0002
894 ALOPECIA 38 0.0002
895 HEADACHE 120 0.0002
896 NERVOUSNESS 10 0.0002
897 SEDATION 5 0.0002
898 JOINT SWELLING 23 0.0002
899 DEPRESSED MOOD 10 0.0002
900 HYPOAESTHESIA 28 0.0002
901 FLUSHING 19 0.0002
902 FREQUENT BOWEL MOVEMENTS 5 0.0002
903 MYOCARDIAL INFARCTION 32 0.0002
904 MOOD ALTERED 5 0.0002
905 ANAPHYLACTIC REACTION 10 0.0002
906 MOBILITY DECREASED 13 0.0002
907 COMPLETED SUICIDE 15 0.0002
908 WOUND 5 0.0002
909 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
910 SINUSITIS 18 0.0002
911 INTENTIONAL DOSE OMISSION 5 0.0002
912 INCORRECT DOSE ADMINISTERED 40 0.0002
913 MEMORY IMPAIRMENT 24 0.0002
914 MUSCLE SPASMS 32 0.0002
915 PROSTATE CANCER 14 0.0002
916 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
917 EXTRA DOSE ADMINISTERED 7 0.0002
918 BURNING SENSATION 12 0.0002
919 INJECTION SITE SWELLING 13 0.0002
920 INJECTION SITE PAIN 52 0.0002
921 HEPATIC CANCER 4 0.0002
922 DEVICE LEAKAGE 7 0.0002
923 AGEUSIA 4 0.0002
924 DRUG INEFFECTIVE 208 0.0002
925 THERAPY NON-RESPONDER 7 0.0002
926 RHINORRHOEA 10 0.0002
927 TINNITUS 7 0.0002
928 BLOOD CHOLESTEROL INCREASED 7 0.0002
929 LIP SWELLING 5 0.0001
930 RHEUMATOID ARTHRITIS 17 0.0001
931 DRUG EFFECT DECREASED 8 0.0001
932 DRY MOUTH 12 0.0001
933 ANXIETY 42 0.0001
934 MULTIPLE SCLEROSIS 7 0.0001
935 DEATH 126 0.0001
936 DRUG ABUSE 12 0.0001
937 NEOPLASM PROGRESSION 5 0.0001
938 DRY EYE 7 0.0001
939 PRODUCT DOSE OMISSION 9 0.0001
940 HOSPITALISATION 21 0.0001
941 NASAL CONGESTION 8 0.0001
942 EYE SWELLING 5 0.0001
943 INFLUENZA LIKE ILLNESS 11 0.0001
944 DEPRESSION 30 0.0001
945 ILL-DEFINED DISORDER 8 0.0001
946 EPILEPSY 4 0.0001
947 SKIN EXFOLIATION 11 0.0001
948 PSORIASIS 17 0.0001
949 INJURY 9 0.0001
950 DISEASE RECURRENCE 6 0.0001
951 INJECTION SITE BRUISING 10 0.0001
952 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
953 WITHDRAWAL SYNDROME 5 0.0001
954 ACNE 9 0.0001
955 WHEEZING 7 0.0001
956 THERAPY CESSATION 6 0.0001
957 GASTRIC DISORDER 4 0.0001
958 PRODUCT DOSE OMISSION ISSUE 34 0.0001
959 VAGINAL HAEMORRHAGE 5 0.0001
960 DERMATITIS ATOPIC 6 0.0001
961 INJECTION SITE ERYTHEMA 14 0.0001
962 FEELING ABNORMAL 27 0.0001
963 SEIZURE 13 0.0001
964 ARTHROPATHY 6 0.0001
965 HOT FLUSH 8 0.0001
966 CONVULSION 6 0.0001
967 EYE IRRITATION 6 0.0001
968 SURGERY 6 0.0001
969 BLADDER CANCER 6 0.0001
970 INJECTION SITE REACTION 7 0.0001
971 DRUG DOSE OMISSION 16 0.0001
972 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
973 DEVICE DISLOCATION 4 0.0001
974 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
975 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
976 ADVERSE DRUG REACTION 8 0.0001
977 SUICIDAL IDEATION 8 0.0001
978 ADVERSE EVENT 8 0.0001
979 MIGRAINE 8 0.0001
980 IRRITABILITY 5 0.0001
981 PRODUCT STORAGE ERROR 7 0.0001
982 AGGRESSION 4 0.0001
983 DEVICE ISSUE 7 0.0001
984 DRY SKIN 10 0.0001
985 EMOTIONAL DISTRESS 9 0.0001
986 PRODUCT QUALITY ISSUE 10 0.0001
987 THERAPY INTERRUPTED 5 0.0001
988 UNEVALUABLE EVENT 5 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
990 NO ADVERSE EVENT 5 0.0000